Schedule a Cognivue DEMO Today 
Follow Us
©2024 Cognivue, Inc. | Privacy Policy | References
Avant Institute In Partnership With Cognivue Awarded Grant to Launch Innovative Early Detection Program For Alzheimer’s In Pharmacies Nationwide
Avant Institute is One of Twelve Select Recipients of the Inaugural Global Davos Alzheimer’s Collaborative Grant Program for Healthcare System Preparedness CHARLOTTE, NC (JUNE 8, 2022) – Avant Institute, in partnership with…
Cognivue Recruits Top Scientists for Clinical Advisory Board
ROCHESTER, NY, March 22, 2022 – Neuroscience company Cognivue, Inc. has recruited eight highly respected professionals in the fields of neuroscience, geriatric medicine, psychiatry, and medicine for its new clinical advisory board….
Cognivue and American Institute of Balance Partner to Expand Cognitive Screening
ROCHESTER, N.Y., January 10, 2022—Neuroscience company Cognivue, Inc. has partnered with American Institute of Balance (AIB) to make its cognitive screening products and services available to the AIB provider network of certified…
New Paper Explores Connection Between Vision and Cognitive Function
Dr. Solomon Gould Chronicles His Work with the Cognivue Thrive Screening Device ROCHESTER, N.Y., December 7, 2021—Neuroscience company Cognivue, Inc. has partnered with St. Paul, Minnesota optometrist Solomon Gould, OD on a…
Cognitive Vision Testing in Optometry: Precision “Medicine” for Eye Care
Cognitive Vision Testing in Optometry: Precision “Medicine” for Eye Care By Solomon Gould, OD, MBA Inspired and Supported by Fred Ma, MD, Ph.D., Heather Harris, Mike Pier, OD, Brad Oatney, OD, and…
Cognivue Welcomes Karen Parkyn-Michael as Vice President of Marketing and Strategy
Executive Brings More than 25 Years of Strategic and Commercial Experience in Multinational and Emerging Medical Device Companies ROCHESTER, N.Y., December 2, 2021—Neuroscience company Cognivue, Inc. has named Karen Parkyn-Michael as vice…
Cognivue Launches Real-World Data Collection Project to Study Hearing and Cognitive Function Relationship
12 U.S. Audiology Clinics Participating with the Cognivue ThriveTM Screening Device ROCHESTER, NY, November 16, 2021—Neuroscience company Cognivue, Inc. has launched a nationwide real-world data collection project aimed at confirming a direct…
Cognivue is proud to support Davos Alzheimer’s Collaborative and their global efforts to fight Alzheimer’s Disease
Geneva, 21 September 2021 – The Davos Alzheimer’s Collaborative (DAC) is a global multi-stakeholder partnership that is mobilizing the world against Alzheimer’s disease. DAC announced today it has successfully completed financing of its foundational phase and has launched…
Cognivue, Inc. Initiates Nationwide Clinical Study to Assess Post-COVID-19 Syndrome (Long Haul Syndrome)
ROCHESTER, N.Y., July 8, 2021—Neuroscience company Cognivue, Inc. today announced the initiation of COG-COVID19, an open-label, prospective, two-armed comparison clinical study to assess the impact of COVID-19 on cognitive function. Researchers from…
Cognivue Appoints Douglas L. Beck, Au.D., as Vice President of Clinical Sciences
Beck Brings Four Decades of Experience in Audiology and Communication Disorders and Sciences to Cognivue ROCHESTER, NY (April 12, 2022)—Neuroscience company Cognivue, Inc. has hired Dr. Douglas L. Beck as Vice President…
Avant Institute In Partnership With Cognivue Awarded Grant to Launch Innovative Early Detection Program For Alzheimer’s In Pharmacies Nationwide
Avant Institute is One of Twelve Select Recipients of the Inaugural Global Davos Alzheimer’s Collaborative Grant Program for Healthcare System Preparedness CHARLOTTE, NC (JUNE 8, 2022) – Avant Institute, in partnership with…
Cognivue Recruits Top Scientists for Clinical Advisory Board
ROCHESTER, NY, March 22, 2022 – Neuroscience company Cognivue, Inc. has recruited eight highly respected professionals in the fields of neuroscience, geriatric medicine, psychiatry, and medicine for its new clinical advisory board….
Cognivue and American Institute of Balance Partner to Expand Cognitive Screening
ROCHESTER, N.Y., January 10, 2022—Neuroscience company Cognivue, Inc. has partnered with American Institute of Balance (AIB) to make its cognitive screening products and services available to the AIB provider network of certified…
New Paper Explores Connection Between Vision and Cognitive Function
Dr. Solomon Gould Chronicles His Work with the Cognivue Thrive Screening Device ROCHESTER, N.Y., December 7, 2021—Neuroscience company Cognivue, Inc. has partnered with St. Paul, Minnesota optometrist Solomon Gould, OD on a…
Cognitive Vision Testing in Optometry: Precision “Medicine” for Eye Care
Cognitive Vision Testing in Optometry: Precision “Medicine” for Eye Care By Solomon Gould, OD, MBA Inspired and Supported by Fred Ma, MD, Ph.D., Heather Harris, Mike Pier, OD, Brad Oatney, OD, and…
Cognivue Welcomes Karen Parkyn-Michael as Vice President of Marketing and Strategy
Executive Brings More than 25 Years of Strategic and Commercial Experience in Multinational and Emerging Medical Device Companies ROCHESTER, N.Y., December 2, 2021—Neuroscience company Cognivue, Inc. has named Karen Parkyn-Michael as vice…
Cognivue Launches Real-World Data Collection Project to Study Hearing and Cognitive Function Relationship
12 U.S. Audiology Clinics Participating with the Cognivue ThriveTM Screening Device ROCHESTER, NY, November 16, 2021—Neuroscience company Cognivue, Inc. has launched a nationwide real-world data collection project aimed at confirming a direct…
Cognivue is proud to support Davos Alzheimer’s Collaborative and their global efforts to fight Alzheimer’s Disease
Geneva, 21 September 2021 – The Davos Alzheimer’s Collaborative (DAC) is a global multi-stakeholder partnership that is mobilizing the world against Alzheimer’s disease. DAC announced today it has successfully completed financing of its foundational phase and has launched…
Cognivue, Inc. Initiates Nationwide Clinical Study to Assess Post-COVID-19 Syndrome (Long Haul Syndrome)
ROCHESTER, N.Y., July 8, 2021—Neuroscience company Cognivue, Inc. today announced the initiation of COG-COVID19, an open-label, prospective, two-armed comparison clinical study to assess the impact of COVID-19 on cognitive function. Researchers from…